Luye Pharma Group Ltd.

LYPHF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$6,936$4,937$3,340$5,655
Short-Term Investments$1,897$1,566$1,509$2,867
Receivables$3,521$4,301$3,508$2,355
Inventory$872$912$816$828
Other Curr. Assets$2,462$1,592$1,732$1,414
Total Curr. Assets$15,687$13,308$12,536$10,703
Property Plant & Equip (Net)$5,925$5,891$5,259$5,127
Goodwill$1,090$1,012$1,024$1,042
Intangibles$6,703$6,585$6,503$6,318
Long-Term Investments$2,506$926$1,574$1,968
Tax Assets$112$164$0$145
Other NC Assets$9$1,725$302$187
Total NC Assets$16,344$16,304$14,663$14,787
Other Assets$0$0$0$0
Total Assets$32,031$29,612$27,198$25,491
Liabilities
Payables$663$689$797$767
Short-Term Debt$8,721$7,585$6,669$5,196
Tax Payable$233$435$330$295
Deferred Revenue$0$0$0-$19
Other Curr. Liab.$2,321$2,060$1,979$1,880
Total Curr. Liab.$11,939$10,769$9,774$8,138
LT Debt$3,149$2,736$2,784$3,228
Deferred Rev, NC$182$118$0$0
Deferred Tax Liab, NC$32$36$0$0
Other NC Liab.$187$199$555$596
Total NC Liab.$3,550$3,089$3,339$3,824
Other Liabilities$0$0$0$0
Cap. Leases$57$62$68$71
Total Liabilities$15,489$13,859$13,114$11,962
Equity
Pref Stock$0$0$0$0
Common Stock$486$486$486$486
Retained Earnings$6,694$0$6,447$7,381
AOCI$0$0$0$505
Other Equity$7,513$13,668$6,086$4,159
Total Equity$14,693$14,155$13,019$12,531
Supplemental Information
Minority Interest$1,850$1,599$1,065$997
Total Liab. & Tot. Equity$32,031$29,612$27,198$25,491
Net Debt$4,934$5,384$6,114$2,769